Back to ENGNW
CITADEL ADVISORS LLC ENGNW Position History
enGene Therapeutics Inc. • Healthcare
Quarters held
17
Latest value
$57K
Q2 2026
Peak value
$13.6M
First seen
Q4 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2023 | $185K |
| Q1 2024 | $13.6M |
| Q1 2024 | $27K |
| Q2 2024 | $5.7M |
| Q2 2024 | $46K |
| Q2 2025 | $84K |
| Q3 2025 | $399K |
| Q4 2025 | $229K |
| Q1 2026 | $1M |
| Q2 2026 | $31K |
| Q2 2026 | $53K |
| Q2 2026 | $1.2M |
| Q2 2026 | $57K |
| Q2 2026 | $31K |
| Q2 2026 | $53K |
| Q2 2026 | $1.2M |
| Q2 2026 | $57K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $57K | 32.8K | — | — |
| Q2 2026 | $1.2M | 699.8K | — | — |
| Q2 2026 | $53K | 30.8K | — | — |
| Q2 2026 | $31K | 17.9K | — | — |
| Q2 2026 | $57K | 32.8K | — | — |
| Q2 2026 | $1.2M | 699.8K | — | — |
| Q2 2026 | $53K | 30.8K | — | — |
| Q2 2026 | $31K | 17.9K | — | — |
| Q1 2026 | $1M | 153.9K | — | — |
| Q4 2025 | $229K | 25.4K | — | — |
| Q3 2025 | $399K | 58.4K | — | — |
| Q2 2025 | $84K | 23.0K | — | — |
| Q2 2024 | $46K | 4.9K | — | — |
| Q2 2024 | $5.7M | 608.4K | — | — |
| Q1 2024 | $27K | 1.6K | — | — |
| Q1 2024 | $13.6M | 802.6K | — | — |
| Q4 2023 | $185K | 20.1K | — | — |